|
MYNN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.505800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.311900E-02 |
| Normal-vs-Stage2 |
6.976600E-01 |
| Normal-vs-Stage3 |
4.333000E-01 |
| Normal-vs-Stage4 |
8.199600E-02 |
| Stage1-vs-Stage2 |
4.994400E-01 |
| Stage1-vs-Stage3 |
4.491900E-02 |
| Stage1-vs-Stage4 |
2.418500E-03 |
| Stage2-vs-Stage3 |
4.007800E-01 |
| Stage2-vs-Stage4 |
1.107190E-01 |
| Stage3-vs-Stage4 |
4.551800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.534000E-01 |
| Normal-vs-AfricanAmerican |
1.347810E-01 |
| Normal-vs-Asian |
8.525600E-01 |
| Caucasian-vs-AfricanAmerican |
9.050200E-02 |
| Caucasian-vs-Asian |
7.770600E-01 |
| AfricanAmerican-vs-Asian |
6.711400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.792400E-01 |
| Normal-vs-Female |
8.835800E-02 |
| Male-vs-Female |
1.735910E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.855400E-01 |
| Normal-vs-Age(41-60Yrs) |
4.573400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.578400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.468200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.128000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.091600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.877400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.148800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.058400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.264000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.546200E-02 |
| Normal-vs-Grade 2 |
2.319800E-02 |
| Normal-vs-Grade 3 |
5.544000E-01 |
| Normal-vs-Grade 4 |
1.799160E-03 |
| Grade 1-vs-Grade 2 |
1.790840E-01 |
| Grade 1-vs-Grade 3 |
3.476200E-02 |
| Grade 1-vs-Grade 4 |
9.951700E-04 |
| Grade 2-vs-Grade 3 |
7.984500E-03 |
| Grade 2-vs-Grade 4 |
1.30519999996803E-06 |
| Grade 3-vs-Grade 4 |
1.079720E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.40479999999987E-05 |
| Normal-vs-ccB subtype |
7.268200E-02 |
| ccA subtype-vs-ccB subtype |
3.09969999667814E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.426000E-01 |
| Normal-vs-N1 |
7.441800E-02 |
| N0-vs-N1 |
7.469600E-02 |
|
|
